Find a pharmacy in Klaipeda
Klaipeda, Lithuania's third-largest city and its only deep-water port, supports a pharmacy network of 21 verified outlets in the PillsCard directory — a density that reflects both the resident population of roughly 150,000 and the seasonal influx of ferry passengers, cruise visitors, and Curonian Spit holidaymakers each summer. Outlets cluster densely in the Old Town around Turgaus and Tiltų streets, in the Senamiestis commercial core, and along the H. Manto axis serving the university quarter near Klaipėda University. Newer branches have followed the residential expansion into Mažasis kaimelis, Debrecenas, and the Gandrališkės district. Cross-border patients arrive from Kaliningrad and Latvia for stock not available at home, and Klaipeda's port workers and merchant seafarers rely on rapid script-filling between voyages.
The Lithuanian retail pharmacy market is consolidated rather than fragmented, and Klaipeda mirrors the national pattern: four large chains dominate the street-level landscape. Benu Vaistinė operates several prominent branches across the city, including outlets in the Akropolis shopping centre and along H. Manto, while Gintarinė vaistinė — part of the Euroapotheca group — maintains a similarly broad footprint with multiple locations in Senamiestis and the northern residential districts. Eurovaistinė rounds out the major chains with central branches near Atgimimo aikštė, and Camelia maintains a smaller but visible presence focused on the Old Town. Independent and hospital-affiliated pharmacies remain rare; the Klaipeda University Hospital pharmacy on Liepojos gatvė handles inpatient and specialist dispensing.
Pricing & coverage
Over-the-counter prices in Klaipeda track national norms: a standard pack of ibuprofen mg ( tablets) runs €–€, paracetamol mg packs €–€, and a basic antibiotic course such as amoxicillin €–€ with a valid prescription. Compounded dermatological preparations typically cost €–€. The VLK (National Health Insurance Fund) reimburses prescription medicines on the compensated drug list at , , , or depending on diagnosis and patient category, with pensioners and chronic-disease patients receiving the highest tiers. Pricing rules and the compensated list are published by the